Antibiotic optimization in the difficult-to-treat patient with complicated intra-abdominal or complicated skin and skin structure infections: focus on tigecycline

References

• TownsendMLPoundMWDrewRHTigecycline in the treatment of complicated intra-abdominal and complicated skin and skin structure infectionsTher Clin Risk Manag2007361059107018516315
   PubMedGoogle Scholar
• NicolauDPManagement of complicated infections in the era of antimicrobial resistance: the role of tigecyclineExpert Opin Pharmacother20091071213122219405794
   PubMed Web of Science ®Google Scholar
• McCleanKLSheehanGJHardingGKIntraabdominal infection: a reviewClin Infect Dis19941911001167948510
   PubMed Web of Science ®Google Scholar
• MenichettiFSgangaGDefinition and classification of intra-abdominal infectionsJ Chemother200921Suppl 13419622444
   PubMedGoogle Scholar
• SolomkinJSMazuskiJEBradleyJSDiagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of AmericaSurg Infect (Larchmt)20101117910920163262
   PubMed Web of Science ®Google Scholar
• SartelliMA focus on intra-abdominal infectionsWorld J Emerg Surg20105920302628
   PubMed Web of Science ®Google Scholar
• BariePSManagement of complicated intra-abdominal infectionsJ Chemother199911646447710678788
   PubMed Web of Science ®Google Scholar
• KrobotKYinDZhangQEffect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgeryEur J Clin Microbiol Infect Dis200423968268715322931
   PubMed Web of Science ®Google Scholar
• BlotSde WaeleJJCritical issues in the clinical management of complicated intra-abdominal infectionsDrugs200565121611162016060697
   PubMed Web of Science ®Google Scholar
• NapolitanoLMSawyerRGStevensDLContemporary approaches to complex infectionsSupplement to Contemporary Surgery2006121–16 Available from: http://www.contemporarysurgery.com/uploadedFiles/CSSupp_Infections_1206.pdf. Accessed May 3, 2010.
   Google Scholar
• BrookIMicrobiology and management of abdominal infectionsDig Dis Sci200853102585259118288616
   PubMed Web of Science ®Google Scholar
• EronLJLipskyBALowDEManaging skin and soft tissue infections: expert panel recommendations on key decision pointsJ Antimicrob Chemother200352Suppl 1i3i1714662806
   PubMedGoogle Scholar
• EisensteinBITreatment challenges in the management of complicated skin and soft-tissue infectionsClin Microbiol Infect200814Suppl 2172518226086
   PubMedGoogle Scholar
• NicholsRLOptimal treatment of complicated skin and skin structure infectionsJ Antimicrob Chemother199944Suppl A192310511393
   PubMed Web of Science ®Google Scholar
• FungHBChangJYKuczynskiSA practical guide to the treatment of complicated skin and soft tissue infectionsDrugs200363141459148012834364
   PubMed Web of Science ®Google Scholar
• DiNubileMJLipskyBAComplicated infections of skin and skin structures: when the infection is more than skin deepJ Antimicrob Chemother200453Suppl 2ii37ii5015150182
   PubMedGoogle Scholar
• LoveBLManagement of complicated skin and soft tissue infections in hospitalized patientsUS Pharm2007324HS5HS12
   Google Scholar
• LipskyBAWeigeltJAGuptaVSkin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomesInfect Control Hosp Epidemiol200728111290129817926281
   PubMed Web of Science ®Google Scholar
• MayAKStaffordREBulgerEMTreatment of complicated skin and soft tissue infectionsSurg Infect (Larchmt)200910546749919860574
   PubMed Web of Science ®Google Scholar
• MoetGJJonesRNBiedenbachDJContemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998–2004)Diagn Microbiol Infect Dis200757171317059876
   PubMed Web of Science ®Google Scholar
• RaghavanMLindenPKNewer treatment options for skin and soft tissue infectionsDrugs200464151621164215257625
   PubMed Web of Science ®Google Scholar
• PodnosYDJimenezJCWilsonSEIntra-abdominal sepsis in elderly personsClin Infect Dis2002351626812060876
   PubMed Web of Science ®Google Scholar
• KiVRotsteinCBacterial skin and soft tissue infections in adults: a review of their epidemiology, pathogenesis, diagnosis, treatment and site of careCan J Infect Dis Med Microbiol200819217318419352449
   PubMed Web of Science ®Google Scholar
• BreenJOSkin and soft tissue infections in immunocompetent patientsAm Fam Physician201081789389920353147
   PubMed Web of Science ®Google Scholar
• ZhanCMillerMRExcess length of stay, charges, and mortality attributable to medical injuries during hospitalizationJAMA2003290141868187414532315
   PubMed Web of Science ®Google Scholar
• KlevensRMEdwardsJRRichardsCLJrEstimating health care-associated infections and deaths in US hospitals, 2002Public Health Rep2007122216016617357358
   PubMed Web of Science ®Google Scholar
• GrosecloseSLBrathwaiteWSHallPACenters for Disease Control and PreventionSummary of notifiable diseases – United States, 2002MMWR Morb Mortal Wkly Rep2004515318415123988
   PubMedGoogle Scholar
• SturkenboomMCGoettschWGPicelliGInappropriate initial treatment of secondary intra-abdominal infections leads to increased risk of clinical failure and costsBr J Clin Pharmacol200560443844316187977
   PubMed Web of Science ®Google Scholar
• ThompsonDAMakaryMADormanTPronovostPJClinical and economic outcomes of hospital acquired pneumonia in intra-abdominal surgery patientsAnn Surg2006243454755216552208
   PubMed Web of Science ®Google Scholar
• EdelsbergJBergerAWeberDJClinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infectionsInfect Control Hosp Epidemiol200829216016918179372
   PubMed Web of Science ®Google Scholar
• ReygaertWMethicillin-resistant Staphylococcus aureus (MRSA): prevalence and epidemiology issuesClin Lab Sci200922211111419534445
   PubMedGoogle Scholar
• WoodfordNLivermoreDMInfections caused by gram-positive bacteria: a review of the global challengeJ Infect200959Suppl 1S4S1619766888
   PubMed Web of Science ®Google Scholar
• ReygaertWMethicillin-resistant Staphylococcus aureus (MRSA): molecular aspects of antimicrobial resistance and virulenceClin Lab Sci200922211511919534446
   PubMedGoogle Scholar
• TristanABesMMeugnierHGlobal distribution of Panton-Valentine leukocidin–positive methicillin-resistant Staphylococcus aureus, 2006Emerg Infect Dis200713459460017553275
   PubMed Web of Science ®Google Scholar
• VourliSVagiakouHGanterisGHigh rates of community-acquired, Panton-Valentine leukocidin (PVL)-positive methicillin-resistant S. aureus (MRSA) infections in adult outpatients in GreeceEuro Surveill2009142 p11=19089
   PubMedGoogle Scholar
• LiuYKongFZhangXAntimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneousBr J Dermatol200916161347135019754868
   PubMed Web of Science ®Google Scholar
• TrzcinskiKCooperBSHryniewiczWDowsonCGExpression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureusJ Antimicrob Chemother200045676377010837427
   PubMed Web of Science ®Google Scholar
• KlevensRMMorrisonMANadleJInvasive methicillin-resistant Staphylococcus aureus infections in the United StatesJAMA2007298151763177117940231
   PubMed Web of Science ®Google Scholar
• Institute for Healthcare ImprovementProtecting 5 Million Lives From Harm200612 Available from: http://www.ihi.org/IHI/Programs/Campaign/. Accessed Jul 31, 2008.
   Google Scholar
• KlevensRMEdwardsJRTenoverFCChanges in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992–2003Clin Infect Dis200642338939116392087
   PubMed Web of Science ®Google Scholar
• BoucherHWCoreyGREpidemiology of methicillin-resistant Staphylococcus aureusClin Infect Dis200846Suppl 5S344S34918462089
   PubMed Web of Science ®Google Scholar
• RiceLBEmergence of vancomycin-resistant enterococciEmerg Infect Dis20017218318711294702
   PubMed Web of Science ®Google Scholar
• RiceLBHutton-ThomasRLakticovaVBeta-lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococciJ Infect Dis200418961113111814999616
   PubMed Web of Science ®Google Scholar
• RiceLBAntibiotics and gastrointestinal colonization by vancomycin-resistant enterococciEur J Clin Microbiol Infect Dis2005241280481416362383
   PubMed Web of Science ®Google Scholar
• KlareIKonstabelCMueller-BertlingSSpread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitalsEur J Clin Microbiol Infect Dis2005241281582516374593
   PubMed Web of Science ®Google Scholar
• Abele-HornMVogelUKlareIMolecular epidemiology of hospital-acquired vancomycin-resistant enterococciJ Clin Microbiol200644114009401317005748
   PubMed Web of Science ®Google Scholar
• CarmeliYEliopoulosGMozaffariESamoreMHealth and economic outcomes of vancomycin-resistant enterococciArch Intern Med2002162192223222812390066
   PubMedGoogle Scholar
• NicasioAMKutiJLNicolauDPThe current state of multidrug-resistant gram-negative bacilli in North AmericaAnn Pharmacother20074161077108117472997
   PubMedGoogle Scholar
• RuppMEFeyPDExtended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatmentDrugs200363435336512558458
   PubMed Web of Science ®Google Scholar
• PatersonDLResistance in gram-negative bacteria: enterobacteriaceaeAm J Infect Control2006345 Suppl 1S20S2816813978
   PubMed Web of Science ®Google Scholar
• BradfordPAExtended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threatClin Microbiol Rev200114493395111585791
   PubMed Web of Science ®Google Scholar
• LautenbachEPatelJBBilkerWBExtended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomesClin Infect Dis20013281162117111283805
   PubMed Web of Science ®Google Scholar
• DuBLongYLiuHExtended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcomeIntensive Care Med200228121718172312447513
   PubMed Web of Science ®Google Scholar
• AndersonDJEngemannJJHarrellLJPredictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniaeAntimicrob Agents Chemother20065051715172016641440
   PubMed Web of Science ®Google Scholar
• TumbarelloMSanguinettiMMontuoriEPredictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatmentAntimicrob Agents Chemother20075161987199417387156
   PubMed Web of Science ®Google Scholar
• SchwaberMJNavon-VeneziaSKayeKSClinical and economic impact of bacteremia with extended-spectrum-beta-lactamase-producing EnterobacteriaceaeAntimicrob Agents Chemother20065041257126216569837
   PubMed Web of Science ®Google Scholar
• RasmussenBABushKTallyFPAntimicrobial resistance in anaerobesClin Infect Dis199724Suppl 1S110S1208994790
   PubMedGoogle Scholar
• LabbéACBourgaultAMVinceletteJTrends in antimicrobial resistance among clinical isolates of the Bacteroides fragilis group from 1992 to 1997 in Montreal, CanadaAntimicrob Agents Chemother199943102517251910508035
   PubMed Web of Science ®Google Scholar
• HechtDWPrevalence of antibiotic resistance in anaerobic bacteria: worrisome developmentsClin Infect Dis2004391929715206059
   PubMed Web of Science ®Google Scholar
• LiuCYHuangYTLiaoCHIncreasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenemsAntimicrob Agents Chemother20085293161316818625771
   PubMed Web of Science ®Google Scholar
• SnydmanDRJacobusNVMcDermottLALessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005–2007)Clin Infect Dis201050Suppl 1S26S3320067390
   PubMed Web of Science ®Google Scholar
• InuiTHaridasMClaridgeJAMalangoniMAMortality for intra-abdominal infection is associated with intrinsic risk factors rather than the source of infectionSurgery2009146465466119789024
   PubMed Web of Science ®Google Scholar
• SchwachaMGMacrophages and post-burn immune dysfunctionBurns200329111412543039
   PubMed Web of Science ®Google Scholar
• DriesDJManagement of burn injuries – recent developments in resuscitation, infection control and outcomes researchScand J Trauma Resusc Emerg Med20091711419284591
   PubMedGoogle Scholar
• BranskiLKAl-MousawiARiveroHEmerging infections in burnsSurg Infect (Larchmt)200910538939719810827
   PubMed Web of Science ®Google Scholar
• AvniTLevcovichAAd-ElDDProphylactic antibiotics for burns patients: systematic review and meta-analysisBMJ2010340c24120156911
   PubMed Web of Science ®Google Scholar
• KeenEFIIIRobinsonBJHospenthalDRIncidence and bacteriology of burn infections at a military burn centerBurns201036446146820045259
   PubMed Web of Science ®Google Scholar
• GallantJEMooreRDChaissonREProphylaxis for opportunistic infections in patients with HIV infectionAnn Intern Med1994120119329448172439
   PubMed Web of Science ®Google Scholar
• KaplanJEHansonDDworkinMSEpidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapyClin Infect Dis200030Suppl 1S5S1410770911
   PubMed Web of Science ®Google Scholar
• MasurHKaplanJEHolmesKKUS Public Health ServiceInfectious Diseases Society of AmericaGuidelines for preventing opportunistic infections among HIV-infected persons – 2002 Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of AmericaAnn Intern Med20021375 Pt 243547812617574
   PubMed Web of Science ®Google Scholar
• BurmanWJJonesBETreatment of HIV-related tuberculosis in the era of effective antiretroviral therapyAm J Respir Crit Care Med2001164171211435232
   PubMed Web of Science ®Google Scholar
• KatzungBMastersSTrevorABasic and Clinical Pharmacology11th edChicagoMcGraw-Hill2009
   Google Scholar
• ZinnerSHChanging epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteriaClin Infect Dis199929349049410530434
   PubMed Web of Science ®Google Scholar
• SullivanKMDykewiczCALongworthDLPreventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and BeyondHematology200139242111722995
   PubMedGoogle Scholar
• HughesWTArmstrongDBodeyGP2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancerClin Infect Dis200234673075111850858
   PubMed Web of Science ®Google Scholar
• CunhaBAAntibiotic selection for diabetic foot infections: a reviewJ Foot Ankle Surg200039425325710949806
   PubMedGoogle Scholar
• KhanolkarMPBainSCStephensJWThe diabetic footQJM2008101968569518353793
   PubMed Web of Science ®Google Scholar
• NelsonSBManagement of diabetic foot infections in an era of increasing microbial resistanceCurr Infect Dis Rep200911537538219698281
   PubMedGoogle Scholar
• RaoNLipskyBAOptimising antimicrobial therapy in diabetic foot infectionsDrugs200767219521417284084
   PubMed Web of Science ®Google Scholar
• GriffinJPD’ArcyPFA Manual of Adverse Drug Interactions5th edThe NetherlandsElsevier1997
   Google Scholar
• KaufmanMBSimionattoCA review of protease inhibitor-induced hyperglycemiaPharmacotherapy19991911141179917085
   PubMed Web of Science ®Google Scholar
• OwensRCJrAmbrosePGAntimicrobial safety: focus on fluoroquinolonesClin Infect Dis200541Suppl 2S144S15715942881
   PubMed Web of Science ®Google Scholar
• PeaFVialePPavanFFurlanutMPharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapyClin Pharmacokinet20074612997103818027987
   PubMed Web of Science ®Google Scholar
• VilayAMChurchwellMDMuellerBAClinical review: drug metabolism and nonrenal clearance in acute kidney injuryCrit Care200812623519040780
   PubMed Web of Science ®Google Scholar
• BoumanCSDosing of antimicrobial agents in critically-ill patients with acute kidney injury and continuous venvenous haemofiltrationActa Clin Belg Suppl2007236537018284001
   PubMedGoogle Scholar
• KuangDVerbineARoncoCPharmacokinetics and antimicrobial dosing adjustment in critically ill patients during continuous renal replacement therapyClin Nephrol200767526728417542336
   PubMed Web of Science ®Google Scholar
• MushattDMMihmLBDreisbachAWSimonEEAntibiotic dosing in slow extended daily dialysisClin Infect Dis200949343343719580416
   PubMed Web of Science ®Google Scholar
• ReynvoetEVandijckDMBlotSIEpidemiology of infection in critically ill patients with acute renal failureCrit Care Med20093772203220919487937
   PubMed Web of Science ®Google Scholar
• StravitzRTCritical management decisions in patients with acute liver failureChest200813451092110218988787
   PubMed Web of Science ®Google Scholar
• O’GradyJGPostoperative issues and outcome for acute liver failureLiver Transpl200814Suppl 2S97S10118825687
   PubMedGoogle Scholar
• MoonDBLeeSGLiver TransplantationGut Liver20093314516520431740
   PubMed Web of Science ®Google Scholar
• JacobAZhouMWuRWangPThe role of hepatic cytochrome P-450 in sepsisInt J Clin Exp Med20092320321119918313
   PubMed Web of Science ®Google Scholar
• StevensDLBisnoALChambersHFPractice guidelines for the diagnosis and management of skin and soft-tissue infectionsClin Infect Dis200541101373140616231249
   PubMed Web of Science ®Google Scholar
• VinhDCEmbilJMSevere skin and soft tissue infections and associated critical illnessCurr Infect Dis Rep20068537538316934196
   PubMedGoogle Scholar
• HasperDSchefoldJCBaumgartDCManagement of severe abdominal infectionsRecent Pat Antiinfect Drug Discov200941576519149697
   PubMedGoogle Scholar
• EliopoulosGMMicrobiology of drugs for treating multiply drug-resistant Gram-positive bacteriaJ Infect200959Suppl 1S17S2419766885
   PubMed Web of Science ®Google Scholar
• PappasGSaplaouraKFalagasMECurrent treatment of pseudomonal infections in the elderlyDrugs Aging200926536337919552489
   PubMed Web of Science ®Google Scholar
• VinhDCEmbilJMSevere skin and soft tissue infections and associated critical illnessCurr Infect Dis Rep20079541542117880853
   PubMedGoogle Scholar
• ZhanelGGHomenuikKNicholKThe glycylcyclines: a comparative review with the tetracyclinesDrugs2004641638814723559
   PubMed Web of Science ®Google Scholar
• RossiFAndreazziDOverview of tigecycline and its role in the era of antibiotic resistanceBraz J Infect Dis200610320321617568854
   PubMedGoogle Scholar
• DoanTLFungHBMehtaDRiskaPFTigecycline: a glycylcycline antimicrobial agentClin Ther20062881079110616982286
   PubMed Web of Science ®Google Scholar
• HawkeyPFinchRTigecycline: in-vitro performance as a predictor of clinical efficacyClin Microbiol Infect200713435436217359318
   PubMed Web of Science ®Google Scholar
• OlsonMWRuzinAFeyfantEFunctional, biophysical, and structural bases for antibacterial activity of tigecyclineAntimicrob Agents Chemother20065062156216616723578
   PubMed Web of Science ®Google Scholar
• PetersonLRA review of tigecycline – the first glycylcyclineInt J Antimicrob Agents200832Suppl 4S215S22219134522
   PubMedGoogle Scholar
• da SilvaLMNunes SalgadoHRTigecycline: a review of properties, applications, and analytical methodsTher Drug Monit201032328228820431506
   PubMed Web of Science ®Google Scholar
• MacGowanAPTigecycline pharmacokinetic/pharmacodynamic updateJ Antimicrob Chemother200862Suppl 1i11i1618684702
   PubMed Web of Science ®Google Scholar
• RoseWERybakMJTigecycline: first of a new class of antimicrobial agentsPharmacotherapy20062681099111016863487
   PubMed Web of Science ®Google Scholar
• SteinGECraigWATigecycline: a critical analysisClin Infect Dis200643451852416838243
   PubMed Web of Science ®Google Scholar
• FritscheTRSaderHSStilwellMGPotency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000–2004)Diagn Microbiol Infect Dis200552319520116105564
   PubMed Web of Science ®Google Scholar